Clinical Trial Update: The Effect of 0.1% Topical Ciclosporin A for 12-weeks on the Eye Surface Immune Cells in Dry Eyes [NA]

View source ↗

Summary

This clinical trial investigates the effect of 0.1% topical ciclosporin A on eye surface immune cells in Dry Eye Disease. The study status is not yet recruiting…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dry Eye Disease

Drugs mentioned

• Topical ciclosporin A 0.1% (cyclosporine ophthalmic solution 0.1%)

Snippet

Sponsor: The University of New South Wales | Conditions: Dry Eye Disease (DED) | NA | Status: NOT_YET_RECRUITING